Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity.
Differential diagnosis of St. Louis encephalitis virus (SLEV) and West Nile virus (WNV) infections can be complicated due to the high degree of cross-reactivity observed in most serodiagnostic assays. In an effort to provide a more specific diagnostic test, we developed virus-like particle (VLP) antigens with reduced cross-reactivity for both SLEV and WNV by identifying and mutating envelope protein amino acids within the cross-reactive epitopes of VLP expression plasmids. To determine the serodiagnostic discriminatory ability of the antigens with reduced cross-reactivity, a panel of 134 human serum samples collected predominately from North American patients with SLEV or WNV infections was used to evaluate the performance of these novel antigens in imunoglobulin M antibody-capture enzyme-linked immunosorbent assays. Positive/negative ratios and the resulting diagnostic classifications were compared between the mutant and the wild-type (WT) VLPs. The mutant VLP antigens were more specific, with higher positive predictive values and higher likelihood ratios than the WT VLP antigens. Both the SLEV and WNV mutant VLPs greatly reduced the observed cross-reactivity, significantly increasing the specificity and sensitivity of the assay. The use of these novel VLP antigens with reduced cross-reactivity in these serodiagnostic assays and others should lead to more accurate diagnoses of current infections, thereby reducing the need for time-consuming and cumbersome confirmatory plaque-reduction neutralization tests to differentiate between SLEV and WNV infections in North America.
Roberson
Jill A
JA
Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, 3150 Rampart Road, CDC-Foothills Campus, Fort Collins, CO 80521, USA.
Crill
Wayne D
WD
Chang
Gwong-Jen J
GJ
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D003429:Cross Reactions; D004665:Encephalitis Virus, St. Louis / Q000276:immunology*; D004674:Encephalitis, St. Louis / Q000175:diagnosis*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D012698:Serologic Tests; D014771:Virion / Q000276:immunology*; D014901:West Nile Fever / Q000175:diagnosis*; D014902:West Nile virus / Q000276:immunology*
D000914:Antibodies, Viral
Virology. 2007 Apr 10;360(2):398-406
17157348
Radiology. 1983 Sep;148(3):839-43
6878708
J Clin Microbiol. 2000 May;38(5):1823-6
10790107
J Clin Microbiol. 2000 May;38(5):1827-31
10790108
J Clin Microbiol. 2000 Jun;38(6):2232-9
10834982
J Virol. 2001 May;75(9):4040-7
11287553
J Virol. 2001 Aug;75(16):7769-73
11462053
J Virol Methods. 2001 Sep;97(1-2):133-49
11483224
Virology. 1983 Jul 15;128(1):118-26
6192585
Virology. 1989 Jul;171(1):49-60
2472704
Virology. 1990 Aug;177(2):668-75
2371772
Annu Rev Microbiol. 1990;44:649-88
2174669
Virology. 1998 Jul 5;246(2):317-28
9657950
Clin Diagn Lab Immunol. 2004 Nov;11(6):1130-3
15539517
J Virol. 2004 Dec;78(24):13975-86
15564505
Clin Diagn Lab Immunol. 2005 May;12(5):566-74
15879016
J Clin Microbiol. 2005 Jul;43(7):3227-36
16000440
J Virol. 2006 Jul;80(14):6982-92
16809304
J Virol. 2006 Oct;80(19):9557-68
16973559
J Gen Virol. 2007 Apr;88(Pt 4):1169-74
17374760
Mol Cell. 2001 Mar;7(3):593-602
11463384
Clin Diagn Lab Immunol. 2002 May;9(3):544-9
11986257
Virology. 2003 Feb 1;306(1):170-80
12620809
Adv Virus Res. 2003;61:3-65
14714429
J Clin Microbiol. 2004 Oct;42(10):4709-17
15472331
J Virol. 2000 May;74(9):4244-52
10756038